EHRA Premium Access

Incidence of malignant ventricular arrhythmia and identifying risk factors in patients with advanced heart failuure on continuous at home inotropic therapy

Topic: Ventricular Arrhythmias and SCD - Clinical

Congress Presentation

About the speaker

Mr Christopher Grubb

New York (United States of America)
0 follower

8 more presentations in this session

Transmural activation delay to predict the architecture of fibrosis using whole heart histology in patients with non-ischemic cardiomyopathy and ventricular tachycardia

Speaker: Ms C. Glashan (Leiden, NL)

Thumbnail

Quantitative assessment of myocardial scar heterogeneity using texture analysis to predict implantable cardioverter defibrillator therapies using cardiac magnetic resonance imaging

Speaker: Doctor J. Gould (London, GB)

Thumbnail

First line epicardial approach in the setting of complex arrhythmia substrates

Speaker: Doctor C. Bisceglia (Milan, IT)

Thumbnail

Phrenic nerve limitation during epicardial catheter ablation for ventricular tachycardia

Speaker: Doctor K. Okubo (Yokosuka, JP)

Thumbnail

Embolic debris captured by a cerebral protection system during catheter ablation of ventricular tachycardia in patients with ischemic heart disease

Speaker: Doctor C. Heeger (Hamburg, DE)

Thumbnail

Access the full session

Novel aspect in ventricular arrhythmia management

Speakers: Mr C. Grubb, Ms C. Glashan, Doctor J. Gould, Doctor C. Bisceglia, Doctor K. Okubo...
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb